Stockreport

CG Oncology (CGON) Reports Promising Results In BOND-003 Trial [Yahoo! Finance]

CG Oncology, Inc. - Common stock  (CGON) 
PDF therapy, cretostimogene, showing significant efficacy in non-muscle invasive bladder cancer patients. Alongside this, the completion of enrollment in the PIVOT-006 study [Read more]